Sign Up to like & get
recommendations!
2
Published in 2023 at "Clinical trials"
DOI: 10.1177/17407745231177046
Abstract: BACKGROUND Composite time-to-event endpoints are beneficial for assessing related outcomes jointly in clinical trials, but components of the endpoint may have different censoring mechanisms. For example, in the PRagmatic EValuation of evENTs And Benefits of…
read more here.
Keywords:
time event;
wise censoring;
cox;
component wise ... See more keywords